131 related articles for article (PubMed ID: 38391198)
1. Octreotide's role in the management of post-esophagectomy chylothorax.
Deboever N; Feldman H; Eisenberg M; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Hofstetter WL
Dis Esophagus; 2024 Jun; 37(6):. PubMed ID: 38391198
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy.
Fujita T; Daiko H
World J Surg; 2014 Aug; 38(8):2039-45. PubMed ID: 24705804
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors For Chyle Leak After Esophagectomy.
Batool S; Akbar SA; Khan M; Sayyed R; Shakeel O; Syed AA; Khattak S; Khan AR
J Ayub Med Coll Abbottabad; 2019; 31(4):506-511. PubMed ID: 31933300
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.
Zhang C; Zhang H; Wu W; Liu D; Yang D; Zhang M; Lu C
Medicine (Baltimore); 2019 Jul; 98(29):e16599. PubMed ID: 31335742
[TBL] [Abstract][Full Text] [Related]
5. Impact of early enteral feed composition on the rate of chyle leak post-esophagectomy.
Pan S; Cheah L; Bushra R; Ribbits A; Grimes S; ; O'Neill JR
Dis Esophagus; 2024 Jun; 37(6):. PubMed ID: 38366666
[TBL] [Abstract][Full Text] [Related]
6. Selective En Masse Ligation of the Thoracic Duct to Prevent Chyle Leak After Esophagectomy.
Lin Y; Li Z; Li G; Zhang X; Deng H; Yang X; Liu L
Ann Thorac Surg; 2017 Jun; 103(6):1802-1807. PubMed ID: 28385376
[TBL] [Abstract][Full Text] [Related]
7. Octreotide.
Stajich GV; Ashworth L
Neonatal Netw; 2006; 25(5):365-9. PubMed ID: 16989134
[TBL] [Abstract][Full Text] [Related]
8. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
Landvoigt MT; Mullett CJ
Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of neonatal chylothorax with octreotide.
Khatami SF; Parvaresh P
Indian J Pediatr; 2011 Nov; 78(11):1412-4. PubMed ID: 21625833
[TBL] [Abstract][Full Text] [Related]
10. Chyle Leak Following Radical En Bloc Esophagectomy with Two-Field Nodal Dissection: Predisposing Factors, Management, and Outcomes.
Milito P; Chmelo J; Dunn L; Kamarajah SK; Madhavan A; Wahed S; Immanuel A; Griffin SM; Phillips AW
Ann Surg Oncol; 2021 Jul; 28(7):3963-3972. PubMed ID: 33263829
[TBL] [Abstract][Full Text] [Related]
11. Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.
Deboever N; Correa AM; Feldman H; Eisenberg M; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Hofstetter WL
Ann Surg; 2024 Jul; 280(1):91-97. PubMed ID: 38568206
[TBL] [Abstract][Full Text] [Related]
12. New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature.
Ohkura Y; Ueno M; Iizuka T; Haruta S; Tanaka T; Udagawa H
Medicine (Baltimore); 2015 Dec; 94(49):e2214. PubMed ID: 26656358
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative refractory chylothorax which was improved by octreotide acetate].
Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
Mohseni-Bod H; Macrae D; Slavik Z
Pediatr Crit Care Med; 2004 Jul; 5(4):356-7. PubMed ID: 15215005
[TBL] [Abstract][Full Text] [Related]
15. [Octreotide for conservative management of postoperative chylothorax].
Gómez-Caro Andrés A; Marrón Fernández C; Moradiellos Díez FJ; Díaz-Hellín Gude V; Pérez Antón JA; Martín de Nicolás JL
Arch Bronconeumol; 2004 Oct; 40(10):473-5. PubMed ID: 15491540
[TBL] [Abstract][Full Text] [Related]
16. Risk of chyle leak after robotic versus video-assisted thoracoscopic esophagectomy.
Dezube AR; Kucukak S; De León LE; Kostopanagiotou K; Jaklitsch MT; Wee JO
Surg Endosc; 2022 Feb; 36(2):1332-1338. PubMed ID: 33660122
[TBL] [Abstract][Full Text] [Related]
17. Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection.
Swanson MS; Hudson RL; Bhandari N; Sinha UK; Maceri DR; Kokot N
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):723-7. PubMed ID: 26135979
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Intravenous Octreotide Is Safe and May Be Superior to Surgery in Managing Severe Postesophagectomy Chylothorax in High-Risk Patients.
Bello SO; Rahamim J
Ann Thorac Surg; 2015 Jul; 100(1):297-9. PubMed ID: 26140770
[TBL] [Abstract][Full Text] [Related]
19. Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition.
Chan JY; Wong EW; Ng SK; van Hasselt CA; Vlantis AC
Ear Nose Throat J; 2017 Jul; 96(7):264-267. PubMed ID: 28719710
[TBL] [Abstract][Full Text] [Related]
20. Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis.
Kranzfelder M; Gertler R; Hapfelmeier A; Friess H; Feith M
Surg Endosc; 2013 Oct; 27(10):3530-8. PubMed ID: 23708712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
